Current projects
Here is an outline of the research projects currently being funded at top research institutions across the UK by Meningitis UK. The total value of the charity's current research programme is £1,166,657.
Using the HBP1 protein to make a new meningococcal vaccine
Professor Jon Sayers, University of Sheffield
Developing meningococcal vaccines through the gonococcal homologue of factor H binding protein
Professor Christoph Tang, University of Oxford
Evaluating proteins on Meningitis B bacteria for use in a vaccine
Professor John Heckels, University of Southampton
Septicaemia and meningitis in premature babies: defining the role of the developing gut bacteria
Professor Simon Kroll, Imperial College London
Discovering new methods of inhibiting carriage of Neisseria meningitidis
Professor Rob Read, University of Sheffield & Professor Andrew Gorringe, HPA Porton Down
Studying antibody composition after infection with Neisseria lactamica
Dr Nigel Saunders, Brunel University
Studying the immune reaction at mucosal surfaces after vaccination with a meningitis B vaccine
Professor Robert Heyderman, University of Bristol
Using the HBP1 protein as a candidate vaccine for meningococcal disease
Professor Jon Sayers, University of Sheffield
Developing meningococcal vaccines through the gonococcal homologue of factor H binding protein
Professor Christoph Tang, University of Oxford
The vaccine potential of meningococcal proteins identified by immuno-proteomics
Professor John Heckels, University of Southampton
Septicaemia and meningitis in premature neonates: defining the role of the developing intestinal microbiota
Professor Simon Kroll, Imperial College London
Competitive carriage of Neisseria spp.; discovering new methods of inhibiting carriage of Neisseria meningitidis
Professor Rob Read, University of Sheffield & Professor Andrew Gorringe, HPA Porton Down
Development of a novel multivalent Group B meningococcal vaccine based on adenovirus vectors
Dr Christine Rollier, University of Oxford
Microserological determination of N. lactamica induced cross-protective meningococcal immunity
Dr Nigel Saunders, Brunel University
Mechanisms of mucosal immunity to systemic immunisation with a meningococcal serogroup B outer membrane vesicle vaccine at University of Bristol
Professor Robert Heyderman, University of Bristol
Bacterial meningitis in babies under 90 days of age: the current burden of disease
Professor Paul Heath, St. George's, University of London




